Resolving adolescence-onset progressive myoclonic epilepsy with variable phenotypes using whole exome sequencing | [Abstract Book on Global Science Technology and Management Conference • 2023]

Author(s):

1. Muhammad Ilyas: University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi

2. Rafaqat Ishaq: University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi

3. Khajista Tahira: University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi

4. Sadiq Noor Khan: Department of Medical Laboratory Technology, University of Haripur, Khyber, Pakhtunkhwa, Pakistan

5. Ataullah: Applied Genomics Centre and State Key Laboratory of Molecular Neuroscience, Hongkong University of Science and Technology, Division of Life Sciences, Hong Kong

6. Fayaz Ahmad: Department of Biostatistics and Epidemiology School of public health Zhengzhou University Henan, China

7. Umme Habiba: University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi, Pakistan

8. Aatika Minhas: Paediatric Department, Polyclinic Hospital, Islamabad, Pakistan

9. Ghazala Kaukab Raja: University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi, Pakistan

10. Pakeeza Arzoo Shaiq: University Institute of Biochemistry and Biotechnology, PMAS Arid Agriculture University, Rawalpindi, Pakistan

Abstract:

Objective: Progressive myoclonic epilepsies (PMEs) are a group of neurodegenerative disorders most commonly affecting adolescents. It is characterized by generalized myoclonic epilepsy, ataxia, cognitive deficits, and dementia. To date, several PMEs associated genes have been identified with specific phenotypes. However, CLN6 variants with variable phenotypes have not been described with adolescence-onset PMEs in Pakistan. In the current study, we described three individuals affected with autosomal recessive adolescence-onset PMEs from a multiplex Pakistani family with substantially variable clinical phenotypes.Methods: Whole Exome Sequencing (WES) was performed in the proband followed by Sanger sequencing to identify the causative variant(s) which was later verified using bi-directional Sanger sequencing. Results: We identified a homozygous recessive CLN6 variant c.768C>G (p.Asp256Glu) which resides at the TM6-TM7 loop domain of CLN6 a hotspot for CLN6 variants that is currently thought to be typical for PMEs.Conclusion: This study supports and expands the phenotypic spectrum of CLN6 mutations and the importance of considering CLN6 variant c.768C>G in diagnosing adolescence onset progressive myoclonic epilepsy. Moreover, it also indicates variable pathology among these patients with the same CLN6genotype strongly contributes to clinical heterogeneity.

Page(s): 120-120

DOI: DOI not available

Published: Journal: Abstract Book on Global Science Technology and Management Conference, Volume: 0, Issue: 0, Year: 2023

Keywords:

Progressive myoclonic epilepsies , CLN6 , Neuronal ceroid lipofuscinosis

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views